Literature DB >> 6296427

RNA and protein encoded by MH2 virus: evidence for subgenomic expression of v-myc.

C Pachl, B Biegalke, M Linial.   

Abstract

MH2 and MC29 are highly related myc-containing avian retroviruses. We found that MH2, unlike MC29, synthesizes a 2.6-kilobase subgenomic mRNA containing myc sequences as well as sequences from the 5' end of the genome. A 57-kilodalton protein containing myc, but not gag, sequences (p57myc) was detected by hybrid selection and in vitro translation of RNA from MH2-transformed cells. Gradient separation of MH2 intracellular RNAs indicated that p57myc is encoded by the subgenomic RNA. A highly oncogenic MH2 virus variant (MH2YS3) (M. Linial, Virology 119:382-391, 1982) was shown to encode only p57myc and not P100, the previously described MH2-encoded polyprotein (Hu et al., Virology, 89:162-178, 1978). Cells transformed by subclones of this virus synthesized predominantly the 2.6-kilobase RNA rather than genomic 5.4-kilobase RNA. These results suggest that only p57myc is required for maintenance of the transformed state after MH2 infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296427      PMCID: PMC256394     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Avian leukemia viruses: interaction with their target cells in vivo and in vitro.

Authors:  T Graf; H Beug
Journal:  Biochim Biophys Acta       Date:  1978-11-17

2.  The defectiveness of Mill Hill 2, a carcinoma-inducing avian oncovirus.

Authors:  S S Hu; C Moscovici; P K Vogt
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

3.  Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15.

Authors:  K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

5.  Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts.

Authors:  S L Adams; M E Sobel; B H Howard; K Olden; K M Yamada; B de Crombrugghe; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

6.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

7.  Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.

Authors:  B M Paterson; B E Roberts; E L Kuff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

8.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures.

Authors:  R C Strohman; P S Moss; J Micou-Eastwood; D Spector; A Przybyla; B Paterson
Journal:  Cell       Date:  1977-02       Impact factor: 41.582

View more
  25 in total

1.  MC29 virus-coded protein occurs as monomers and dimers in transformed cells.

Authors:  J P Bader; D A Ray
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Transformed and tumorigenic phenotypes induced by avian retroviruses containing the v-mil oncogene.

Authors:  C Béchade; G Dambrine; T David-Pfeuty; E Esnault; G Calothy
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

3.  myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts.

Authors:  S Alema; F Tato; D Boettiger
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

4.  Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII.

Authors:  N Walther; R Lurz; T Patschinsky; H W Jansen; K Bister
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  Isolation of an MH2 retrovirus mutant temperature sensitive for macrophage but not fibroblast transformation.

Authors:  S Palmieri
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Structure and transforming function of transduced mutant alleles of the chicken c-myc gene.

Authors:  T Patschinsky; H W Jansen; H Blöcker; R Frank; K Bister
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Mapping by in vitro constructs of the P100gag-mil region, accounting for induction of chicken neuroretina cell proliferation.

Authors:  J Coll; C Dozier; S Saule; C Henry; B Quatannens; B Debuire; D Stehelin
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Avian carcinoma virus MH2 contains a transformation-specific sequence, mht, and shares the myc sequence with MC29, CMII, and OK10 viruses.

Authors:  N C Kan; C S Flordellis; C F Garon; P H Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

9.  Protein product of proto-oncogene c-mil.

Authors:  T Patschinsky; B Schroeer; K Bister
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

10.  Nucleotide sequence of avian carcinoma virus MH2: two potential onc genes, one related to avian virus MC29 and the other related to murine sarcoma virus 3611.

Authors:  N C Kan; C S Flordellis; G E Mark; P H Duesberg; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.